Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura J Esserman

Showing results (151-160 of 308) with videos related to

Pageof 31
Sort By:
Breast Cancer Research and Treatment|November 29, 2021
A case-case analysis of women with breast cancer: predictors of interval vs screen-detected cancerNickolas Dreher, Madeline Matthys, Edward Hadeler, et al.
JAMA Network Open|June 30, 2021
Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical TrialHuma Dar, Annelie Johansson, Anna Nordenskjöld, et al.
Scientific Reports|December 15, 2020
Evaluation of primary breast cancers using dedicated breast PET and whole-body PETDeep K Hathi, Wen Li, Youngho Seo, et al.
Journal of the National Cancer Institute|January 29, 2017
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based TrialYiwey Shieh, Martin Eklund, Lisa Madlensky, et al.
Cancers|June 13, 2020
Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant TherapyElla F Jones, Deep K Hathi, Rita Freimanis, et al.
Frontiers in Oncology|August 8, 2025
Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY TrialMark Hensley, Justin Lengfeld, Steven Stoesz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2014
Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysisSjoerd G Elias, Arthur Adams, Dorota J Wisner, et al.
Clinical Breast Cancer|July 10, 2019
Fitbit Usage in Patients With Breast Cancer Undergoing ChemotherapyNickolas Dreher, Edward Kenji Hadeler, Sheri J Hartman, et al.
NPJ Breast Cancer|July 2, 2025
Insights from a multi-institutional registry show duration of endocrine treatment for DCIS impacts second eventsThomas J O'Keefe, Christina Yau, Emma Iaconetti, et al.
Proteomics. Clinical Applications|April 29, 2016
Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancersBenjamin A Katchman, Rodrigo Barderas, Rizwan Alam, et al.
Pageof 31

Showing results (151-160 of 308) with videos related to

Sort By:
Pageof 31
Breast Cancer Research and Treatment|November 29, 2021
A case-case analysis of women with breast cancer: predictors of interval vs screen-detected cancerNickolas Dreher, Madeline Matthys, Edward Hadeler, et al.
JAMA Network Open|June 30, 2021
Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical TrialHuma Dar, Annelie Johansson, Anna Nordenskjöld, et al.
Scientific Reports|December 15, 2020
Evaluation of primary breast cancers using dedicated breast PET and whole-body PETDeep K Hathi, Wen Li, Youngho Seo, et al.
Journal of the National Cancer Institute|January 29, 2017
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based TrialYiwey Shieh, Martin Eklund, Lisa Madlensky, et al.
Cancers|June 13, 2020
Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant TherapyElla F Jones, Deep K Hathi, Rita Freimanis, et al.
Frontiers in Oncology|August 8, 2025
Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY TrialMark Hensley, Justin Lengfeld, Steven Stoesz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2014
Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysisSjoerd G Elias, Arthur Adams, Dorota J Wisner, et al.
Clinical Breast Cancer|July 10, 2019
Fitbit Usage in Patients With Breast Cancer Undergoing ChemotherapyNickolas Dreher, Edward Kenji Hadeler, Sheri J Hartman, et al.
NPJ Breast Cancer|July 2, 2025
Insights from a multi-institutional registry show duration of endocrine treatment for DCIS impacts second eventsThomas J O'Keefe, Christina Yau, Emma Iaconetti, et al.
Proteomics. Clinical Applications|April 29, 2016
Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancersBenjamin A Katchman, Rodrigo Barderas, Rizwan Alam, et al.
Pageof 31